Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inflammation in end-stage renal disease--what have we learned in 10 years?

Seminars in dialysis - 1 Jan 2000

Carrero Juan J, Stenvinkel Peter

Abstract excerpt

The first reports connecting uremic inflammation with a wasted and atherogenic phenotype and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on Medline, reflecting the exponential interest that this topic has evoked in nephrology. What was described as a "novel" risk factor 10 years ago has now evolved into an established finding in patients with end-stage renal disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Cardiovascular Diseases
Share to Inflammation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation Mediators

Share to Kidney Failure, Chronic

Share to Prognosis

Share to Renal Dialysis

Share to Uremia

Source

Identifiers

PMID: 21039875
DOI: 10.1111/j.1525-139X.2010.00784.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inflammation in end-stage renal disease--what have we learned in 10 years?PMID 21039875Read ↗

Inflammation in end-stage renal disease--a fire that burns within.Semantic proximity Read ↗

Beyond Blood Pressure: Emerging Pathways and Precision Approaches in Hypertension-Induced Kidney DamageSemantic proximity Read ↗

Molecular Mechanisms of Diabetic Kidney DiseaseSemantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

New insights into the role of immunity and inflammation in diabetic kidney disease in the omics eraSemantic proximity Read ↗

The pathogenesis of diabetic nephropathy.Semantic proximity Read ↗

Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: systemic inflammation and aging - a mini-review.Semantic proximity Read ↗

Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel TherapiesSemantic proximity Read ↗

Are inflammatory cytokines the "evil humors" that increase morbidity and cardiovascular mortality in chronic kidney disease?Semantic proximity Read ↗

Epigenetically regulated inflammation in vascular senescence and renal progression of chronic kidney diseaseSemantic proximity Read ↗

Inflammation: A New Look at an Old ProblemSemantic proximity Read ↗

End‐stage renal disease – not an equal opportunity disease: the role of genetic polymorphismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.